title: A cardiologist's perspective on cardiometabolic risk.
abstract: Many patients who present for cardiovascular evaluation meet the National Cholesterol Education Program (NCEP) criteria for the metabolic syndrome. Indeed, the metabolic abnormalities that characterize the syndrome are major drivers of atherosclerosis. Although definitive therapeutic interventions for the metabolic syndrome remain unclear, considerable data implicate adiposity as a core element of this constellation of abnormalities. Thus, for practicing cardiologists, the need to better understand and target adiposity is inescapable.
authors.affiliation: Vascular Disease Prevention Program, Cardiovascular Division, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. jplutzky@rics.bwh.harvard.edu
authors.forename: Jorge
authors.initials: J
authors.lastname: Plutzky
mesh_terms: D050154:Adiposity / Q000502:physiology; D050197:Atherosclerosis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D002784:Cholesterol / Q000097:blood; D006801:Humans; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D015995:Prevalence; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D002784:Cholesterol